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SIV progressionare targeted to different degrees by SIV infection. We studied central memory,
effector memory, naïve, and regulatory T cell levels longitudinally in 11 SIVmac251-infected pigtail macaques.
Depletion of CD28+CD95+ central memory CD4+ T cells, but not other populations, correlated with both SIV
viral load and disease progression. A low pre-infection level of central memory CD4+ T cells was also
predictive of rapid disease progression. If conﬁrmed in larger studies, our results suggest stratifying
macaques for baseline central memory CD4+ T cells would be useful in deﬁning both the pathogenesis of SIV
disease and SIV vaccine efﬁcacy.
© 2008 Elsevier Inc. All rights reserved.IntroductionLong-term immunity to viruses is facilitated by the generation and
persistence of virus-speciﬁc memory T cells. Virus-speciﬁc T cells are
comprised of both central memory (CM) T cells which are long-lived
andprovide a continuous source of effector Tcells and effectormemory
(EM) T cells which possess immediate effector functions capable of
clearing virus. In human immunodeﬁciency virus (HIV) and simian
immunodeﬁciency virus (SIV) the ability to generate and sustain CM
and EM CD4+ T cells is impeded by direct infection and killing of
memory CD4+ T cells (Groot et al., 2006; Mattapallil et al., 2005;
Nishimura et al., 2007; Okoye et al., 2007;Wang et al., 2007). Although
severalmarkers have been used to deﬁne CMTcells (Okoye et al., 2007)
the combination of monoclonal antibodies (mAbs) CD28 and CD95
effectively discriminates CD4+ naïve andmemory Tcell subsets in rhesus
macaques (Pitcher et al., 2002; Sun et al., 2007). It was recently reported
that preservation of CD28+CD95+ CM CD4+ T cells during chronic
infection is strongly associated with survival but not control of viremia
in vaccinated rhesus macaques challenged with SIV (Letvin et al., 2006).
Subsequent studies of unvaccinated SIV-infected rhesus and cynomol-
gus macaques have shown a positive correlation between loss of CM
CD4+ T cells and viral load (Karlsson et al., 2007a; Nishimura et al., 2007;
Sun et al., 2007). Thus, CM CD4+ T cell counts may function as a useful
surrogate marker for the effectiveness of SIV or HIV vaccines. However,l rights reserved.the relationship between loss of CM CD4+ T cells and control of viremia
or survival has not been assessed in the pathogenic model of SIV
infection of pigtail macaques (Macaca nemestrina).
In recent years, there has been increased interest in CD25+
FoxP3+ regulatory CD4+ T cells (Tregs). However, it is unclear whe-
ther Tregs dampen potentially useful virus-speciﬁc immune respon-
ses (Estes et al., 2006) or limit harmful T cell hyperactivation (Legrand
et al., 2006) since depletion of Tregs in vitro enhances the ability to
detect HIV-speciﬁc T cell immunity (Aandahl et al., 2004; Kinter et al.,
2004) yet Treg depletion in HIV infection is also associated with
immune activation (Eggena et al., 2005). The comparative role of Tregs
and memory T cell subsets in controlling SIV disease progression has
not been deﬁned in pigtail macaques. Low surface expression of the
IL-7 receptor (CD127) has recently been used to deﬁne Tregs that
express intracellular FoxP3+ in humans (Liu et al., 2006; Seddiki et al.,
2006). The CD25+CD127low phenotype is also characteristic of Tregs in
rhesus macaques although in contrast to humans, CD3+CD4+CD25+
cells in this species are uniformly CD127low and FoxP3+ (Hartigan-
O'Connor et al., 2007). Whether this phenotype is also applicable to
pigtail macaque Tregs is not known.
We undertook a longitudinal prospective analysis of the memory,
naïve and Treg CD4+ T cell populations to examine changes in speciﬁc
CD4+ T cell subsets and their relationship to control of viremia and
survival in a pathogenicmodel of SIV infection of pigtail macaques.We
also sought to determine whether pre-infection baseline levels of CM
CD4+ T cells or Tregs in peripheral blood could serve as surrogate
markers for survival or disease progression in SIV infection.
Table 1
Progressor status of 12 SIVmac251-infected pigtail macaques
Group Animal CD4+ T cell count
(×103/μl)
Viral load (log10
RNA copies/ml)
Time of
euthanasia
(weeks p.i.)Baseline Nadir Peak Mean
(weeks 5–23)
Rapid progressor 5807 1.866 0.970 6.81 5.85 16
5773 3.329 1.232 7.29 5.76 19
6115 2.839 0.582 7.05 6.25 19
6267 1.593 0.602 8.09 7.78 19
Conventional
progressor
3C7D 3.618 1.008 6.77 5.68 23
3117 2.350 0.726 6.98 5.82 23
6258 2.013 0.376 7.36 6.07 23
6288 1.972 0.446 6.78 5.24 23
6361 1.428 0.230 6.85 5.25 23
Slow progressor 5612 1.857 1.047 6.59 3.45 n/a
5831 3.047 1.343 6.09 4.89 n/a
6158 2.409 1.094 7.02 4.87 n/a
12 Rapid CommunicationResults and discussion
SIV-infected, untreated pigtail macaques have variable disease
progression
We examined naïve and memory CD4+ T cell subsets in 12
SIVmac251-infected pigtail macaques from a recently completed
vaccine study (Kent et al., 2008). Six of the 12 animals were vaccina-
ted with a recombinant Kunjin virus expressing SIV Gag, the other 6
were unvaccinated controls. No vaccine related immune responses
were induced and disease progression following challenge with
SIVmac251 was identical between the 2 groups (Kent et al., 2008). As
expected, the 12 animals had variable success in controlling SIV
replication in the absence of treatment and were grouped into rapid,
conventional and slow progressor (RP, CP and SP, respectively)
groups based on a composite criteria of survival time and mean set
point viral load 5–23 weeks post-infection (p.i.) (Figs. 1a,b and
Table 1). We identiﬁed three SP (5612, 5831 and 6158). Animal 5612
reduced viral load to below the detection threshold (b1500 copies/
mL) while 5831 and 6158 remained healthy with low but detectable
viremia. All 3 SP survived more than 1 year following SIV infection.Fig. 1. Analysis of viral load, survival and CD4+ T cell counts in SIV-infected, untreated pigtail
load and (c) CD3+CD4+ T cell counts in slow (SP), conventional (CP) and rapid progressor (R
memory (CD28+CD95+) CD3+CD4+ T cell counts and plasma viral load 10 weeks p.i. (two-taile
into terciles (based on central memory (CD28+CD95+) CD3+CD4+ T cells/ml [lowb200; middThere were 4 RP (5773, 5807, 6115 and 6267) who were unable to
control viral replication and were euthanized with incipient AIDS 16
to 19 weeks post-infection. The remaining 5 animals (3C7D, 3117,macaques. Longitudinal analysis of (a) individual viral loads and mean (±SE) of (b) viral
P) macaques; † denotes all animals in group deceased. (d) Correlation between central
d p-value) and (e) Kaplan Meier survival graph for SIV-infected pigtail macaques divided
le 200–400; highN400] (Log rank test p-values).
13Rapid Communication6258, 6288 and 6361) had generally intermediate levels of VL and
progressive SIV disease and required euthanasia, primarily with
weight loss, diarrhoea and lethargy at 23 weeks p.i (between that of
RP and SP animals). The criteria for euthanasia were set prospectively
and included weight loss (N10%), loss of appetite, diarrhoea, clinical
disease consistent with infection or malignancy and/or reduced
activity in the setting of consistently elevated SIV viral loads. Animal
6258 was not studied for longitudinal memory CD4 T cell subsets
analyses due to poor separation between memory and naïve subsets
based on CD95 expression during acute SIV infection (data not
shown).
Total, baseline and nadir CD4+ T cell counts do not account for different
disease progression phenotypes
We ﬁrst examined whether variable disease outcomes in the 11
untreated pigtail macaques was due to differences in total CD4+ T cells
and CD4 subset counts. CD4+ T cell subsets were delineated by ﬂow
cytometry in fresh whole blood samples. A gradual depletion of total
CD4+ T cells was observed in all animals, but there was no statistical
difference between the three groups (nonparametric Mann Whitney
ranksum pN0.4, Fig. 1c). Group baseline (week 0) total CD4+ T cell
counts were not statistically different and nadir CD4+ T cell counts,
deﬁned as the lowest measured CD4+ T cell count, were only
marginally different between the SP and CP groups (p=0.04, two-
tailed t-test) (Table 1).
Preservation of central memory CD4+ T cells in SIV-infected pigtail
macaques is associated with survival and control of viremia
The lack of a strong association between total CD4+ T cells and
disease progression of SIV-infected pigtail macaques, suggested that
examining subsets of CD4+ T cells may reveal depletion of memoryFig. 2. Longitudinal analysis of memory and naïve CD4+ T cell subsets in SIV-infected, untreat
effector memory (CD28−CD95+) and (c) central memory (CD28+CD95+) CD3+CD4+ T cell couCD4+ T cells as reported for rhesus and cynomolgus macaques
(Karlsson et al., 2007a; Sun et al., 2007). We therefore examined
central memory (CM), effector memory (EM) and naive T cell subsets
in serial blood samples pre- and post-infection based on well-
validated CD28 and CD95 expression patterns (Picker et al., 2004;
Pitcher et al., 2002). To assess the interplay between CD4+ T cell
subsets and disease progression in SIV infection, we examined
longitudinal data of memory and naïve CD4+ T cells in the 11 SIV-
infected pigtail macaques. There was a highly signiﬁcant inverse
correlation between CD28+CD95+ CM CD4+ T cells and viral load
[p=0.008 (two-tailed), R2=0.647] during chronic SIV infection [Fig.
1d]. We also analyzed the groups by terciles of CM CD4+ T cells (low
b200, middle 200–400 and high N400 CM CD4+ T cells/μl) and
observed that preservation of CM CD4+ T cells in the highest tercile
was associated with survival in untreated macaques [Fig. 1e]. Thus,
preservation of CM CD4+ T cells was associated with both survival and
control of viremia in SIV-infected pigtail macaques.
Rapid progressors have low CM CD4+ T cell counts pre- and post-SIV
infection
Since there was a strong relationship between post acute CM CD4+
T cell concentration and the outcome of SIV infection, we extended
this analysis for the duration of SIV infection. Longitudinal analysis of
CD4+ T cell subsets showed no difference in naïve and EM CD4+ T cell
counts between SP, CP and RP throughout acute and chronic SIV
infection (nonparametric Mann Whitney ranksum p-valuesN0.14)
[Figs. 2a and b]. However, there was a trend towards overall retention
of CM CD4+ T cell counts over time in SP compared with CP or RP
(nonparametric Mann Whitney ranksum p-values; both p=0.03) [Fig.
2c]. Interestingly, we also noted higher naïve CD4+ T cell and lower CM
CD4+ Tcell levels pre-infection in the RP group, as shown in theweek 0
timepoint of Figs. 2a and c.ed pigtail macaques. Longitudinal analysis of mean (±SE) of (a) naïve (CD28+CD95−), (b)
nts and (d) central memory to naïve CD3+CD4+ T cell ratios in SP, CP and RP macaques.
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Given the apparent signiﬁcance of baseline CM CD4+ T cell levels to
disease outcome, we compared CM:naïve CD4+ T cell ratios in the 3
groups. The RP’s demonstrated uniformly low CM:naïve CD4 T cell
ratios which were signiﬁcantly lower both pre- and post-infection
(p=0.04, 0.006 respectively) than CP and SP groups combined [Fig.
2d]. Both SP controllers and CP had a decline in CM:naïve CD4+ T cell
ratios during acute infection but were able to restore CM:naïve CD4+ T
cell ratios close to pre-infection levels. CM:naïve CD4+ Tcell ratios over
time between SP and CP groups were almost identical. RP animals,
however, experienced a continuous decline in the ratio of CM to naïve
CD4+ T cells throughout SIV infection as compared with CP and SP
(nonparametric Mann Whitney ranksum p=0.08, 0.03 respectively).
Treg levels do not predict disease progression
Given the proposed Treg suppression of virus-speciﬁc T cell
immunity, we sought to examine peripheral CD4+ Tregs over time in
the 11 SIV-infected macaques. Intracellular staining for FoxP3 on
CD4+CD25+ T cells deﬁnes regulatory T cells, but is technically
cumbersome and does not allow for subsequent functional analyses.
We recently reported a simple surface staining method to deﬁne Tregs
as CD25+CD127lo CD4+ T cells in humans (Seddiki et al., 2006) and
adapted this assay to pigtail macaque T cells. The CD25+CD127lo CD4+ T
cell population robustly deﬁned the same CD25+FoxP3+ population of
Tregs in all 11 pigtail macaques [Fig. 3a] and is consistent with Treg
phenotype observed in rhesus macaques (Hartigan-O'Connor et al.,
2007). We then used this assay to surface stain fresh peripheral blood
over the course of SIV infection [Fig. 3b]. Therewas no difference in Treg
numbers pre-infection and depletion in total Tregs during the course of
SIV infection in all 3 progressor populations. The pattern of rapid
decline in Tregs following acute SIV infection with subsequent rebound
and thenmore gradual decline during chronic SIV infection is similar to
that reported for Tregs in SIV-infected cynomologus macaques
(Karlsson et al., 2007b).
In summary, we evaluated the relationship between memory and
Treg subsets of CD4+ T cells with survival and disease progression in
SIV-infected pigtail macaques. Preservation of CM CD4+ T cells was
associated with survival in pigtail macaques, consistent with previous
reports in rhesus macaques (Letvin et al., 2006). In accordance with
previous studies of rhesus and cynomolgus macaques (Karlsson et al.,
2007a; Sun et al., 2007), we observed a signiﬁcant association
between preservation of CM CD4+ T cells and control of viremia inFig. 3. CD4+ T regulatory (Treg) cell analysis in SIV-infected, untreated pigtail macaques. (a) C
Treg cell population; gates drawn based on CD25, CD127 and FoxP3 ﬂuorescence minus one
analysis of mean (±SE) of CD25+CD127lo CD4+ Treg cell counts in SP, CP and RP macaques.SIV-infected pigtail macaques. Given the strong associations between
viral levels and disease outcome, an association between CM CD4+ T
cells and VL is not unexpected.
Our longitudinal analysis of CM, EM, naïve and Treg CD4+ T cell
subsets in 12 treatment naïve SIV-infected pigtail macaques showed
an unexpected ﬁnding of low baseline CM CD4+ T cells in rapid
progressors, but not other CD4+ T cell subsets. Low pre-infection levels
of CM CD4+ T cells predicting SIV disease has not been reported in
rhesus macaques although it is unclear whether this has been
carefully studied in the rhesus-SIV model (Letvin et al., 2006; Okoye
et al., 2007). In our experience pigtail macaques progress more rapidly
to AIDS in comparison to rhesus macaques (Batten et al., 2006). We
speculate that the more rapid progression in the pigtail macaque
model may make animals with lower pre-infection levels of CM CD4+
T cells more vulnerable to rapid progression in comparison to models
with slower disease progression. Further analyses on even larger
cohorts of SIV-infected macaques are clearly warranted. Depletion of
already low CM CD4+ T cell levels might predispose to disease
progression and, if conﬁrmed in larger studies, should be taken into
account in randomizing macaques for pathogenesis and vaccine
studies.
Materials and methods
Animals and viruses
Twelve SIVmac251-infected pigtail macaques (M. nemestrina) exam-
ined in this study were part of a recently completed failed Kunjin
replicon SIV vaccine trial (Kent et al., 2008) approved by the University
of Melbourne animal ethics committee. The SIVmac251 (kindly supplied
by Drs N. Miller and R. Pal) was injected IV at 40 TCID50. Plasma SIV
RNA levels were determined by real-time PCR as previously described
(Fernandez et al., 2007). Prospective criteria for euthanasia for
incipient AIDS, agreed with our animal ethics committee, were weight
loss (N10%), loss of appetite, persistently reduced activity, chronic
diarrhoea, or clinical disease consistent with infection or malignancy.
Phenotyping of CD4+ T cell subsets
Staining of CD4+ Tcell subsets was performed on freshwhole blood
collected in sodium heparin vacuette tubes. 250 μl of whole blood was
stained for 1 h at room temperature with a monoclonal antibody
cocktail containing either i) anti-CD3 allophycocyanin (APC) clone
SP34-2, anti-CD4 phycoerythrin-Cy7 (PE-Cy7) clone SK3, anti-CD28o-staining of CD4+ T cells for CD25+ and CD127lo identiﬁes equivalent CD25+Foxp3+ CD4+
(FMO) controls (performed for all animals and shown for animal 6267). (b) Longitudinal
15Rapid Communicationperidinin-chlorophyll-protein complex Cy5.5 (PerCP Cy5.5) clone
L293 and anti-CD95 ﬂuorescein isothiocyanate (FITC) clone DX2 (all
from BD Biosciences) for phenotyping of naïve, CM and EM CD4+ T
cells or ii) anti-CD4 (FITC) clone M-T477 (BD Biosciences), anti-CD25
(APC) 2A3 (BD Biosciences) clone L293 and anti-CD127 phycoerythrin
(PE) clone R34.34 (Beckman Coulter, Fullerton, CA, USA) for pheno-
typing of Tregs. After red blood cells were lysed at room temperature
for 10 min with 2 ml BD FACS Lysing Solution (BD Biosciences), the
cells were washed with 2 ml FACS wash buffer (PBS, 0.5% BSA, 2 mM
EDTA, pH 8). For Treg samples requiring intracellular FoxP3 staining,
cells were permeabilized at room temperature for 10 minwith 0.5 mL
BD FACS Permeabilizing Solution 2 (BD Biosciences), washed with
3.5 mL FACS wash buffer then incubated for 1 h at room temperature
with anti-human FoxP3 (FITC) clone 206D (BioLegend, San Diego, CA,
USA). A ﬁnal wash with PBS was performed and the cells were ﬁxed
with 1% formaldehyde. Fluorescence minus one (FMO) controls for
CD25, CD28, CD95, CD127 and FoxP3 were included in each run.
Samples were acquired on a BD LSR II ﬂow cytometer (BD Bioscience)
within 3 h of staining and compensation was optimized using BD
CompBeads (BD Biosciences). At least 50,000 CD4+ T cell events were
collected for each sample and subsequent data analyses were
performed using FlowJo Version 7.2.2 for Windows (Treestar, Ashland,
OR, USA). Statistical analyses used nonparameteric Mann Whitney
ranksum tests to compare levels of T cells subsets over time in
macaques groups.
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